ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 2 filers reported holding ICU MED INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $399 | -58.1% | 4 | -50.0% | 0.00% | – |
| Q3 2023 | $952 | +33.5% | 8 | +100.0% | 0.00% | – |
| Q2 2023 | $713 | +8.0% | 4 | 0.0% | 0.00% | – |
| Q1 2023 | $660 | +4.8% | 4 | 0.0% | 0.00% | – |
| Q4 2022 | $630 | -37.0% | 4 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 4 | -42.9% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 7 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $2,000 | 0.0% | 7 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | 0.0% | 7 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | +100.0% | 7 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 7 | -50.0% | 0.00% | -100.0% |
| Q1 2020 | $2,000 | -77.8% | 14 | -73.6% | 0.00% | -80.0% |
| Q4 2019 | $9,000 | 0.0% | 53 | -14.5% | 0.01% | +25.0% |
| Q3 2019 | $9,000 | -35.7% | 62 | +10.7% | 0.00% | -33.3% |
| Q2 2019 | $14,000 | -73.1% | 56 | -58.8% | 0.01% | -45.5% |
| Q1 2019 | $52,000 | +85.7% | 136 | +8.8% | 0.01% | -15.4% |
| Q4 2018 | $28,000 | -20.0% | 125 | 0.0% | 0.01% | -7.1% |
| Q3 2018 | $35,000 | -14.6% | 125 | -12.6% | 0.01% | -17.6% |
| Q2 2018 | $41,000 | +13.9% | 143 | 0.0% | 0.02% | +13.3% |
| Q1 2018 | $36,000 | +12.5% | 143 | -4.7% | 0.02% | +15.4% |
| Q4 2017 | $32,000 | +14.3% | 150 | -2.0% | 0.01% | -13.3% |
| Q3 2017 | $28,000 | -17.6% | 153 | -22.7% | 0.02% | -21.1% |
| Q2 2017 | $34,000 | -35.8% | 198 | -43.3% | 0.02% | -34.5% |
| Q1 2017 | $53,000 | -1.9% | 349 | -5.7% | 0.03% | -6.5% |
| Q4 2016 | $54,000 | +12.5% | 370 | -3.1% | 0.03% | +14.8% |
| Q3 2016 | $48,000 | +11.6% | 382 | -0.5% | 0.03% | +8.0% |
| Q2 2016 | $43,000 | +7.5% | 384 | -1.0% | 0.02% | +4.2% |
| Q1 2016 | $40,000 | -13.0% | 388 | -5.4% | 0.02% | -17.2% |
| Q4 2015 | $46,000 | – | 410 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |